Latest / The Joe Rogan Recap / Brigham Buhler (2025) - Big Pharma, Corrupt Systems and Unexplained Phenomena

Transcript

Brigham Buhler (2025) - Big Pharma, Corrupt Systems and Unexplained Phenomena · The Joe Rogan Recap

• 0:00
  Welcome to the Joe Rogan recap. Today, we're taking a deep dive
• 0:03
  into a recent conversation that really pulls back the curtain on
• 0:08
  some truly fascinating and maybe sometimes unsettling aspects of
• 0:12
  our world. Our mission here is to pull out
• 0:14
  the most important insights from this discussion, trying to cut
• 0:17
  through the noise, you know, to get to the core of what matters
• 0:20
  for you. Exactly.
• 0:21
  And when we unpack a discussion as well as wide-ranging as this
• 0:25
  one, it's not just about the specific facts they lay out.
• 0:27
  It's more about understanding how things connect, you know,
• 0:30
  systems connecting our personal health, our choices to these big
• 0:33
  global power structures. What's really fascinating, I
• 0:36
  think, is this consistent thread running through it, questioning
• 0:39
  the narratives we usually accept, always looking for
• 0:41
  deeper truths. It definitely challenges you to
• 0:43
  look beyond just the headlines. OK, right, let's get into it.
• 0:48
  So we dive straight into some pretty significant claims about
• 0:50
  how familiar institutions might be operating in ways many of us
• 0:54
  just wouldn't expect. Our sources introduce us to
• 0:57
  someone with first hand experience.
• 1:00
  Started out it was a drug Rep for Eli Lilly actually.
• 1:03
  And the claim to have seen behind the curtain, you know,
• 1:06
  describing this long history of blowing the whistle on what they
• 1:09
  call systemic issues. Yeah, their account paints a
• 1:12
  really vivid picture of corruption, collusion and
• 1:15
  corporate capture right across major organizations.
• 1:18
  We're talking EPA, CDC, NIH, FDA, the big ones.
• 1:22
  What's really striking is this argument that these systems,
• 1:25
  well, instead of being truly independent regulatory bodies,
• 1:28
  were maybe as the source puts it, born in captivity.
• 1:30
  Born in captivity. Wow.
• 1:32
  Yeah, it implies they were influenced, maybe even shaped by
• 1:36
  powerful industries right from the beginning.
• 1:38
  I mean, think about those historical claims like
• 1:40
  Rockefeller and petroleum based medicine, or the example
• 1:45
  mentioned in the discussion, the CDC's headquarters allegedly
• 1:49
  gifted by Coca-Cola. And apparently there were even
• 1:52
  emails talking about how to shut down bad information on sugar.
• 1:55
  It really makes you question the foundations, doesn't it?
• 1:58
  That phrase born in captivity is just incredibly provocative.
• 2:02
  And the source doesn't just stick to broad claims, right?
• 2:05
  They offer some pretty striking anecdotes to back this up.
• 2:08
  And here's where it gets, well, really interesting, maybe a bit
• 2:11
  weird. We hear this story about a
• 2:13
  high-ranking CDC official allegedly seen wearing a
• 2:16
  pentagram dog collar. Now, the point the source makes
• 2:19
  isn't really about the collar itself, but about what this
• 2:22
  official was apparently worried about the potential removal of
• 2:25
  hepatitis B shots for babies. Right.
• 2:27
  The implication being a direct financial motive that these
• 2:30
  shots are quote paying. Exactly.
• 2:32
  This anecdote, strange as it sounds, is presented as evidence
• 2:35
  that the government side of things runs deeper, darker and
• 2:38
  is more controlled than people think, with industry lobbying
• 2:42
  actively obstructing, delaying, denying anything that might
• 2:46
  threaten their bottom line. It's definitely meant to
• 2:49
  highlight this perceived subversion of how we think these
• 2:54
  institutions should work, their priorities.
• 2:56
  And this alleged influence isn't just based on anecdotes.
• 2:58
  The discussion brings up a really critical point about
• 3:00
  funding. Like, if 60% of the FDA's budget
• 3:03
  comes directly from industry fees, well, how does that shave
• 3:07
  their decisions? You have to ask.
• 3:08
  That's a. Huge percentage.
• 3:09
  It is, and the source gives the stark example, supposedly from
• 3:13
  an insider's view after a meeting with the FDA that
• 3:16
  seemed, you know, positive, receptive.
• 3:19
  They were apparently warned, pardon the language, they're
• 3:21
  going to smile F you and then just ramrod all the things they
• 3:24
  wanted anyway, regardless of the concerns brought up.
• 3:26
  It really speaks to this idea of a revolving door, you know,
• 3:29
  between government and industry, suggesting the influence is just
• 3:32
  deeply baked in, almost impossible to untangle.
• 3:34
  OK, so then our deep dive kind of zooms in on a really hot
• 3:37
  topic right now, GLP ones. You've probably heard about
• 3:40
  them, those blockbuster weight loss peptides, Ozempic we go V
• 3:44
  that sort of thing. We learned these actually
• 3:46
  started out at the National Institutes of Health, NIH,
• 3:50
  taxpayer funded. But now there's this crucial
• 3:53
  battle being fought over them about who controls, how they're
• 3:56
  made distributed, and who really benefits in the end.
• 3:59
  Yeah, what's really fascinating here is this claim that the big
• 4:02
  pharmaceutical companies like Eli Lilly and Novo Nordisk are
• 4:06
  lobbying the FDA hard to basically capture peptides.
• 4:10
  Their argument is that compounding pharmacies, the ones
• 4:13
  making custom versions, are dangerous, their products
• 4:16
  unsafe, kind of painting them as unreliable.
• 4:18
  But the discussion presents this really contrasting picture.
• 4:21
  It points to FDA warning letters sent against these very pharma
• 4:24
  giants, citing issues like get this cat hair and pest activity
• 4:28
  in their sterile manufacturing room.
• 4:29
  Seriously, cat hair. Apparently.
• 4:31
  And Eli Lilly allegedly destroying records and hiding
• 4:35
  clinical data, whereas compounding pharmacies, the
• 4:38
  source tells us, often get inspected more frequently,
• 4:40
  sometimes several times a year. It kind of flips the script on
• 4:43
  who's potentially riskier, doesn't it?
• 4:45
  It really does. So, OK, what does all this mean
• 4:47
  for, you know, for you, the patient who's trying to get
• 4:49
  these medications? Our source argues that the big
• 4:51
  pharma approach often leads to overdosing people or quickly
• 4:56
  pushing patients to higher dosages.
• 4:58
  And the claim isn't that it's for better results, but because,
• 5:01
  well, as they put it, it reimburses more through
• 5:05
  insurance. Higher dose, higher payout.
• 5:07
  Right, whereas compounders reportedly often micro dose,
• 5:11
  they might even combine GLP ones with other things like IGF, LR3.
• 5:15
  It's a type of growth factor that can help preserve lean
• 5:18
  muscle mass, which is a common concern with rapid weight loss,
• 5:22
  right? You lose muscle too.
• 5:23
  So compounders offer this more personalized cash pay option and
• 5:27
  it's way cheaper, like couple 100 bucks a month versus maybe
• 5:31
  $1300 a month retail. It aims to be more tailored,
• 5:34
  maybe mitigate side effects versus this kind of standardized
• 5:38
  higher profit approach. That difference in cost is huge
• 5:41
  and the personalization aspect. It really brings up this
• 5:43
  important question about access and choice for patients.
• 5:47
  We hear about the FDA. They allowed an exemption for
• 5:51
  compounders to make these drugs when there were shortages, but
• 5:54
  then they let it expire. Why?
• 5:55
  Based on industry claims that big Pharma could meet the
• 5:58
  demand, But could they? Well, according to a 12 month
• 6:01
  study mentioned in this discussion, apparently less than
• 6:03
  6% of the lower dosages were actually available from the big
• 6:07
  companies, which if true, effectively forces patients into
• 6:10
  those higher dose, more expensive options if they want
• 6:13
  to get the drug through standard channels.
• 6:15
  So the shortage wasn't really over, at least not for the
• 6:17
  starting doses. That's the implication.
• 6:20
  And there's also this significant push we hear to
• 6:23
  reclassify peptides like GOP ones as biologics.
• 6:28
  OK, what does that mean practically?
• 6:29
  Well, biologics are a category of drugs usually made from
• 6:32
  living sources. They often get much longer
• 6:35
  patent protection. So this move would apparently
• 6:38
  extend patent life from maybe five years to 12 years, granting
• 6:42
  monopolies. And the source argues this would
• 6:44
  basically kill off competition from compounders and stifle
• 6:48
  innovation, especially in newer fields like telemedicine that
• 6:51
  use these peptides. Wow.
• 6:53
  OK. So it's not just about specific
• 6:55
  drugs, is it? This deep dive goes broader,
• 6:57
  challenging some really widely accepted health ideas, things
• 7:01
  that feel like common knowledge, like, for example, this idea of
• 7:04
  a chemical imbalance being the main cause of depression.
• 7:07
  Yeah, that's a big one. Our source says that theory is
• 7:09
  well, largely been disproven and was actually perpetuated and
• 7:13
  created their words by big pharma to sell drugs.
• 7:16
  That's a strong claim. It is.
• 7:18
  And we also hear how the diagnostic tools like the
• 7:21
  questionnaires for ADHD and depression allegedly developed
• 7:24
  by consultants who were working for pharmaceutical companies,
• 7:28
  making the diagnosis kind of simplistic, very subjective, you
• 7:31
  know, no objective blood tests or brain scans involved usually.
• 7:34
  Indeed, and one of the most maybe surprising claims
• 7:39
  challenges how we think about common treatments like SSRI's
• 7:42
  antidepressants. They were reportedly found in
• 7:45
  studies to be only about two points higher than a placebo on
• 7:48
  a 52 point depression scale. Only two points out of 52.
• 7:52
  Yeah, and the discussion highlights that this difference
• 7:55
  isn't really considered statistically relevant, which
• 7:58
  makes you really look critically at how effective these widely
• 8:01
  prescribed drugs actually are for many people.
• 8:03
  So what works better according to the source?
• 8:05
  Well, what's compelling is the alternative view presented that
• 8:09
  exercise is five times more potent for treating depression.
• 8:11
  Five times and things like red light therapy is even higher.
• 8:15
  But these options rarely get the same kind of mainstream
• 8:18
  promotion, do they? No, definitely not.
• 8:20
  And we also hear about this alleged connection between
• 8:23
  SSRI's and suicidal ideation and violent thoughts, and even a
• 8:29
  suggested correlation with school shootings, which is
• 8:32
  almost never discussed in mainstream media.
• 8:34
  That's heavy stuff. It really makes you wonder,
• 8:37
  like, what information are we actually getting and why?
• 8:41
  The argument made is that the media is often, you know,
• 8:44
  sponsored by the same pharmaceutical companies, which
• 8:47
  leads to a kind of silence on these more critical issues.
• 8:49
  Yeah, they use this very vivid example.
• 8:51
  A congresswoman allegedly seen drinking a Coke while listening
• 8:55
  to testimony about removing ultra processed foods from food
• 8:58
  stamps. Right.
• 8:59
  I remember hearing that. It's a small detail maybe, but
• 9:02
  it's used to illustrate this perceived entanglement of
• 9:05
  interests. You know, industry influence
• 9:07
  everywhere. So the broader point, which is
• 9:09
  pretty unsettling, is that a lot of what we're taught, what
• 9:12
  doctors learn in healthcare, might actually be wrong.
• 9:15
  Or at least outdated or incomplete.
• 9:16
  The source quotes a Stanford professor suggesting at least at
• 9:19
  minimal 60% might be wrong, which is just a staggering
• 9:24
  figure to think about. It is, And another really
• 9:27
  critical area the discussion digs into is why depression
• 9:30
  rates apparently skyrocketed in the 80s.
• 9:33
  Was it just better diagnosis or something else?
• 9:36
  The conversation suggests this compelling link to the rise of
• 9:40
  ultra processed food diets and how that impacts our insulin
• 9:43
  response, our gut health, inflammation.
• 9:47
  Maybe that's a bigger driver than just brain chemistry alone.
• 9:49
  So it reframes the whole issue. Exactly.
• 9:51
  It encourages us to look critically at all these systemic
• 9:54
  influences on our health, from the food industry pushes to
• 9:57
  maybe outdated medical textbooks.
• 9:59
  And it's not just food. They also mentioned we need to
• 10:02
  consider how our bodies are being affected by things we
• 10:04
  don't even think about, like microplastics, these tiny
• 10:07
  plastic bits that are apparently now being found even in the
• 10:10
  human brain. In the brain.
• 10:12
  Wow, what does that even mean long term?
• 10:14
  We don't fully know yet, and that's part of the point, and
• 10:16
  there's so much we might be exposed to or told that needs
• 10:19
  more scrutiny. What a journey this has been.
• 10:21
  I mean, from that complex dance between pharma giants and
• 10:25
  regulators, to how our diet fundamentally effects our mental
• 10:28
  health, and even questioning the very basics of accepted medical
• 10:32
  knowledge, this deep dive has definitely given us, and
• 10:35
  hopefully you, a lot to think about.
• 10:37
  Really feels like a powerful reminder, doesn't it, about
• 10:40
  seeking out different perspectives, questioning the
• 10:42
  status quo, especially when our health is on the line.
• 10:46
  Absolutely. I think this whole conversation
• 10:47
  really underscores that knowledge isn't just about
• 10:50
  gathering facts. It's most valuable when you
• 10:53
  understand it and can actually apply it.
• 10:55
  So whether that means exploring alternative health approaches
• 10:57
  the source touches on, like peptides or even psychedelics,
• 11:01
  or just understanding the forces shaping our food or drugs, or
• 11:05
  even thinking about humanity's future with things like AI and
• 11:08
  gene editing which also come up, the real core message seems to
• 11:11
  be about critical thinking. It's really encouraging you to
• 11:14
  try and reclaim some agency over your own health and over the
• 11:17
  information landscape that surrounds you.
• 11:20
  Don't just accept things passively.
• 11:22
  Right. So as you reflect on this deep
• 11:24
  dive, maybe consider this question.
• 11:26
  What if the biggest conspiracy quote, UN quote, isn't some
• 11:29
  secret group in a dark room, but just the collective, often
• 11:32
  unexamined acceptance of narratives that happen to serve
• 11:35
  profit more than they serve our well-being?
• 11:37
  And what if the most revolutionary thing you can do
• 11:39
  is simply to keep asking why, and to trust your own informed
• 11:43
  curiosity to lead you towards deeper truths?